Treatment of Staphylococcal Urinary Tract Infection

Key Diagnostic Considerations

The American Academy of Pediatrics recommends distinguishing between pathogenic and contaminant staphylococci, with coagulase-negative staphylococci not considered clinically relevant urine isolates in otherwise healthy patients 1

The American Academy of Pediatrics suggests that culture is mandatory to document true UTI and guide antimicrobial management 3
For catheterized patients with catheters in place ≥2 weeks, the Infectious Diseases Society of America recommends replacing the catheter and obtaining culture from the fresh catheter before initiating therapy 4
Antimicrobial sensitivities should be used to adjust initial empiric therapy, as recommended by the European Urology Association 2, 3

The European Urology Association recommends basing initial antibiotic choice on local antimicrobial sensitivity patterns and antibiograms 1, 3
Patient-specific factors, including allergies, prior culture data, and recent antibiotic exposure, should be considered when selecting empiric therapy, as suggested by the European Urology Association 2, 5
For complicated UTI with systemic symptoms, the European Urology Association recommends using combination therapy, such as amoxicillin plus aminoglycoside or second-generation cephalosporin plus aminoglycoside 2, 5

The European Urology Association recommends a standard duration of 7-14 days for treatment, with 7 days for patients with prompt symptom resolution and 10-14 days for delayed response or when prostatitis cannot be excluded in men 2, 4, 5

The Infectious Diseases Society of America recommends removing or replacing indwelling catheter if present ≥2 weeks to hasten symptom resolution in catheter-associated staphylococcal UTI 4
The American Academy of Pediatrics suggests that oral or parenteral routes are equally efficacious for treatment in pediatric patients, with a duration of 7-14 days 1

The Journal of Urology recommends not treating asymptomatic bacteriuria, as it fosters antimicrobial resistance and increases recurrent UTI risk, except in pregnant women and patients undergoing invasive urinary procedures 7, 8
The European Urology Association recommends avoiding fluoroquinolones for empiric therapy if local resistance rate is ≥10% or patient is from urology department or used fluoroquinolones in last 6 months 5

The American Academy of Pediatrics recommends adjusting therapy based on culture results, tailoring antibiotics according to susceptibility testing once available 1, 3
The Journal of Urology suggests repeating urine culture to assess for ongoing bacteriuria before prescribing additional antibiotics if symptoms persist despite treatment 8